On the other hand, a previous study comparing NAFLD with no-NAFLD subjects suggested a greater utilization of 18:0 along the SCD1 pathway in NAFLD rather than elongase pathway [10]. This evidence concerns the gene SCD and metabolic dysfunction-associated steatotic liver disease.